A Study to Assess THN391 in Subjects With Alzheimer's Disease

Clinical trial NCT06814730 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06814730
Sponsor: Therini Bio, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease, Early Onset

Start date: 2025-07-17
Primary completion: 2027-03-31
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.